Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 24/11/22 → 23/11/24 |
Keywords
- Clinical Trials
- Medical Oncology
- ASKG315
Clinical Trial Phase
- Phase I
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ASKG315 as a Single Agent and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors
- Markman, Ben (Primary Chief Investigator (PCI))
- Brooks, Christine (Project Manager)
Project: Research